234 related articles for article (PubMed ID: 33711965)
1. A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma.
Wu JY; Sun JX; Wu JY; Huang XX; Bai YN; Zeng YY; Zhang ZB; Cheng SQ; Yan ML
BMC Cancer; 2021 Mar; 21(1):272. PubMed ID: 33711965
[TBL] [Abstract][Full Text] [Related]
2. Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.
Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Tsuruga Y; Kamachi H; Taketomi A
Ann Surg Oncol; 2016 Aug; 23(8):2627-34. PubMed ID: 27006124
[TBL] [Abstract][Full Text] [Related]
3. Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?
Rammohan A; Sathyanesan J; Rajendran K; Pitchaimuthu A; Perumal SK; Balaraman K; Ramasamy R; Palaniappan R; Govindan M
HPB (Oxford); 2015 Jun; 17(6):508-13. PubMed ID: 25639610
[TBL] [Abstract][Full Text] [Related]
4. Prognosis for patients with hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) after surgical treatment.
Lin Z; Han M; Zhou Z
Biosci Trends; 2019 Mar; 13(1):77-85. PubMed ID: 30814401
[TBL] [Abstract][Full Text] [Related]
5. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma.
Li P; Huang W; Wang F; Ke YF; Gao L; Shi KQ; Zhou MT; Chen BC
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30254101
[No Abstract] [Full Text] [Related]
6. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
Zhang T; Liu Z; Zhao X; Mao Z; Bai L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
[No Abstract] [Full Text] [Related]
7. Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection: a matched study.
Wang DD; Wu LQ; Wang ZS
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):626-632. PubMed ID: 27919852
[TBL] [Abstract][Full Text] [Related]
8. Obstructive jaundice due to intraductal tumour thrombus in recurrent hepatocellular carcinoma: what is the optimal therapeutic approach?
Xin KY; Yee LS; Yong TT; Fui AC
Hepatogastroenterology; 2014 Oct; 61(135):1863-6. PubMed ID: 25713879
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus.
Oba A; Takahashi S; Kato Y; Gotohda N; Kinoshita T; Shibasaki H; Ikeda M; Konishi M
Anticancer Res; 2014 Aug; 34(8):4367-72. PubMed ID: 25075073
[TBL] [Abstract][Full Text] [Related]
10. Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study.
Kim JM; Kwon CHD; Joh JW; Sinn DH; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
Medicine (Baltimore); 2015 Feb; 94(6):e450. PubMed ID: 25674733
[TBL] [Abstract][Full Text] [Related]
11. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus.
Wong TC; Cheung TT; Chok KS; Chan AC; Dai WC; Chan SC; Poon RT; Fan ST; Lo CM
HPB (Oxford); 2015 May; 17(5):401-8. PubMed ID: 25410794
[TBL] [Abstract][Full Text] [Related]
13. A special recurrent pattern in small hepatocellular carcinoma after treatment: bile duct tumor thrombus formation.
Liu QY; Lai DM; Liu C; Zhang L; Zhang WD; Li HG; Gao M
World J Gastroenterol; 2011 Nov; 17(43):4817-24. PubMed ID: 22147984
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesion.
Zhou D; Hu GF; Gao WC; Zhang XY; Guan WB; Wang JD; Ma F
World J Gastroenterol; 2020 Nov; 26(44):7005-7021. PubMed ID: 33311946
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion.
Kasai Y; Hatano E; Seo S; Taura K; Yasuchika K; Uemoto S
World J Surg; 2015 Jun; 39(6):1485-93. PubMed ID: 25651961
[TBL] [Abstract][Full Text] [Related]
16. A proposed modification for the Barcelona Clinic Liver Cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma.
Lu WP; Tang HW; Yang ZY; Jiang K; Chen YL; Lu SC
Am J Surg; 2020 Oct; 220(4):965-971. PubMed ID: 32336518
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study.
Moon DB; Hwang S; Wang HJ; Yun SS; Kim KS; Lee YJ; Kim KH; Park YK; Xu W; Kim BW; Lee DS; Lee DH; Kim HJ; Lim JH; Choi JS; Park YH; Lee SG
World J Surg; 2013 Feb; 37(2):443-51. PubMed ID: 23188531
[TBL] [Abstract][Full Text] [Related]
19. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.
Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S
Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma with bile duct tumor thrombus: dynamic computed tomography findings and histopathologic correlation.
Liu QY; Zhang WD; Chen JY; Li HG; Liu C; Liang BL
J Comput Assist Tomogr; 2011; 35(2):187-94. PubMed ID: 21412088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]